Let's turn
your breakthrough
into business
Kevin Antonio Cahya
Co-Founder & Managing Partner
M.Eng. Bioengineering, UC Berkeley
Kevin developed end-to-end technical expertise across the biotech value chain—beginning with discovery research at UW-Madison, advancing into translational protein development at Bio-Techne, and culminating in large-scale process optimization and automation at Eli Lilly and Merck.Building on this foundation, he transitioned into Eli Lilly's business development and later deepened his exposure to the startup landscape at Berkeley SkyDeck, Berkeley StEP, and LBNL, while earning his Master's in Bioengineering at UC Berkeley. Post-graduation, he explored venture formation through Hesperian Ventures, and currently serves with Nucleate and multiple VC firms as a venture scout.At ScaleBio Partners, Kevin draws on this multidisciplinary journey to help biotech startups sharpen their technical narratives, refine commercialization strategies, and prepare effectively for fundraising and strategic partnerships.
Prisca Josephine Sanusi
Co-Founder & Scientific Partner
M.Sc. Biotechnology Innovations, Sorbonne University
Prisca has built her career at the intersection of science, business, and entrepreneurship. With a background spanning molecular and cellular biology, biotechnology, and innovation management, she transitioned from scientific research at Sorbonne University and Institut Jacques Monod into innovation consulting, advising startups and SMEs across biotechnology, healthtech, diagnostics, medical devices, and other deep-tech sectors.Through her work at Novanexia, she has helped companies secure competitive European funding and develop the strategic foundations needed to bring breakthrough technologies to market, from commercialization planning and business development to investor engagement.At ScaleBio Partners, Prisca leverages her combined scientific and business expertise to help founders bridge the gap between research and market adoption, guiding technology positioning, fundraising efforts, strategic partnerships, and long-term growth planning.
